Sec Form 4/A Filing - KATZAROFF JAMES C @ GlobeStar Therapeutics Corp - 2021-05-12

FORM 4/A Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person KATZAROFF JAMES C 2. Issuer Name and Ticker or Trading Symbol GlobeStar Therapeutics Corp [ GSTC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) CEO (Last) (First) (Middle) 719 JADWIN AVE. 3. Date of Earliest Transaction (MM/DD/YY) 05/12/2021 (Street) RICHLAND, WA99352 4. If Amendment, Date Original Filed (MM/DD/YY) 04/03/2023 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common stock 04/03/2023 04/03/2023 J( 1 ) 7,042,253 A $ 0.0071 17,042,253 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Options $ 0.03 05/12/2021 A 30,000,000 05/12/2021 05/12/2023 Common stock 30,000,000 $ 0 30,000,000 D Options $ 0.009 02/24/2023 A 35,000,000 ( 2 ) 08/24/2023( 3 ) 02/24/2028 Common stock 35,000,000 $ 0 65,000,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other KATZAROFF JAMES C 719 JADWIN AVE. RICHLAND, WA99352 X CEO Signatures James C. Katzaroff 04/04/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Shares acquired pursuant to conversion of debt of $50,000. ( 2 )Options vest 50% when granted and balance ratably on a daily basis during the 24 month period commencing on date of grant. ( 3 )Vested Options are exercisable 6 months after date of grant and thereafter until 5 years after the date of grant.

Remarks: This Form 4/A Amendment No. 1 is being filed to correct a typographical error in Table I, box 4 on the original Form 4 filing. The shares acquired pursuant to conversion of debt of $50,000 has been corrected from 70,422,535 to 7,042,253.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.